Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01M QUINOLONE ANTIBACTERIALS
J01MA Fluoroquinolones
J01MA17 Prulifloxacin
D01144 Prulifloxacin (JAN/INN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
624 Synthetic antibacterials
6241 Pyridonecarboxylic acids
D01144 Prulifloxacin (JAN/INN)
Drug groups [BR:br08330]
Antibacterial
DG01550 Quinolone
DG01549 Fluoroquinolone
D01144 Prulifloxacin
Drug classes [BR:br08332]
Antibacterial
DG01549 Fluoroquinolone
D01144 Prulifloxacin
Antimicrobials [BR:br08307]
Antibacterials
Nucleic acid synthesis inhibitor
Fluoroquinolone
D01144 Prulifloxacin (JAN/INN) <JP>
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Nucleic acid synthesis inhibitor
Fluoroquinolone
D01144 Prulifloxacin (JAN/INN)
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D01144
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01144
Prodrugs [br08324.html]
D01144